Skip to content
10-Q

Quarterly Report

Design Therapeutics, Inc. DSGN

0001193125-25-266970

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 56.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.95M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.56M sh
Capex Q3 2025 · Sep 30, 2025 $159K
Capex Q3 2025 · Sep 30, 2024 $340K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$42.39M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$33.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $15.09M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $22.56M
Stockholders Equity Q3 2025 · Sep 30, 2025 $199.72M
Stockholders Equity Q3 2025 · Jun 30, 2025 $213.04M
Stockholders Equity Q3 2025 · Dec 31, 2024 $242.1M
Stockholders Equity Q3 2025 · Sep 30, 2024 $252.45M
Stockholders Equity Q3 2025 · Jun 30, 2024 $261.24M
Stockholders Equity Q3 2025 · Dec 31, 2023 $277.69M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.17M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.46M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.05M
Total Liabilities Q3 2025 · Dec 31, 2024 $10M
Current Assets Q3 2025 · Sep 30, 2025 $209.03M
Current Assets Q3 2025 · Dec 31, 2024 $248.04M
Total Assets Q3 2025 · Sep 30, 2025 $211.77M
Total Assets Q3 2025 · Dec 31, 2024 $252.09M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.95
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.23
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.64
Eps Basic Q3 2025 · Sep 30, 2025 −$0.30
Eps Basic Q3 2025 · Sep 30, 2025 −$0.95
Eps Basic Q3 2025 · Sep 30, 2024 −$0.23
Eps Basic Q3 2025 · Sep 30, 2024 −$0.64
Sga Expense Q3 2025 · Sep 30, 2025 $4.72M
Sga Expense Q3 2025 · Sep 30, 2025 $15.59M
Sga Expense Q3 2025 · Sep 30, 2024 $4.37M
Sga Expense Q3 2025 · Sep 30, 2024 $13.5M
Rd Expense Q3 2025 · Sep 30, 2025 $14.59M
Rd Expense Q3 2025 · Sep 30, 2025 $45.7M
Rd Expense Q3 2025 · Sep 30, 2024 $11.88M
Rd Expense Q3 2025 · Sep 30, 2024 $32.19M
Net Income Q3 2025 · Sep 30, 2025 −$17M
Net Income Q3 2025 · Sep 30, 2025 −$53.8M
Net Income Q3 2025 · Sep 30, 2024 −$13.04M
Net Income Q3 2025 · Sep 30, 2024 −$35.94M
Operating Income Q3 2025 · Sep 30, 2025 −$19.31M
Operating Income Q3 2025 · Sep 30, 2025 −$61.3M
Operating Income Q3 2025 · Sep 30, 2024 −$16.25M
Operating Income Q3 2025 · Sep 30, 2024 −$45.69M